Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 378,318 |
|
|||||
| News | (1) | ||||||
| Day High | 0.4737 | Low High |
|||||
| Day Low | 0.44 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Affimed NV | AFMD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.026 | 5.78% | 0.476 | 19:57:19 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.4737 | 0.44 | 0.4737 | 0.4544 | 0.45 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,215 | 378,318 | $ 0.4550769 | $ 172,164 | - | 0.2235 - 2.15 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:35:12 | 3 | $ 0.4759 | USD |
Affimed NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 68.7M | 149.34M | - | 42.77M | -86M | -0.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Affimed NV News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AFMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.4715 | 0.55 | 0.411 | 0.4855483 | 648,146 | 0.0045 | 0.95% |
| 1 Month | 0.364 | 0.55 | 0.3106 | 0.422095 | 737,026 | 0.112 | 30.77% |
| 3 Months | 0.53 | 0.55 | 0.2235 | 0.4270893 | 628,441 | -0.054 | -10.19% |
| 6 Months | 0.878 | 0.878 | 0.2235 | 0.5506248 | 788,029 | -0.402 | -45.79% |
| 1 Year | 2.08 | 2.15 | 0.2235 | 0.8971006 | 1,016,191 | -1.60 | -77.12% |
| 3 Years | 5.25 | 11.74 | 0.2235 | 4.83 | 1,492,670 | -4.77 | -90.93% |
| 5 Years | 4.55 | 11.74 | 0.2235 | 4.38 | 1,240,208 | -4.07 | -89.54% |
Affimed NV Description
| Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany. |
